Refine by
Influenza Season Equipment & Supplies
14 equipment items found
Manufactured by:OPTI Medical Systems, Inc. based inRoswell, GEORGIA (US) (USA)
OPTI Medical Systems has obtained CE marking for its OPTI SARS-CoV-2/Influenza A/B RT-PCR Test for identification and differentiation of SARS-CoV-2, influenza A, and influenza B RNA. The test is available in countries accepting the CE mark. This respiratory panel distinguishes between SARS-CoV-2 and influenza A and B extracted ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major contributor to acute respiratory infection and pneumonia with rates of pneumonia (Clinics in Chest Medicine 2017) and hospitalization (JID 2012) similar to that of RSV and influenza. RSV, hMPV, and influenza ...
Manufactured by:Eurofins Built Environment Testing EMLab P&K based inSouth San Francisco, CALIFORNIA (USA)
The swine flu or H1N1 virus is a subtype of influenza virus A, the most common cause of flu in humans. Some strains of H1N1 are endemic in humans and cause a small fraction of all influenza-like illness and a large fraction of all seasonal ...
Manufactured by:Eurofins Built Environment Testing EMLab P&K based inSouth San Francisco, CALIFORNIA (USA)
The swine flu or H1N1 virus is a subtype of influenza virus A, the most common cause of flu in humans. Some strains of H1N1 are endemic in humans and cause a small fraction of all influenza-like illness and a large fraction of all seasonal ...
Manufactured by:Ellume Limited based inEast Brisbane, AUSTRALIA
We have developed a single use flu test that can detect influenza from the comfort of the user’s own home. The test connects to the user’s smartphone through the test’s designated app. Test results are displayed on the user’s phone within 12 minutes of completing the ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
With the ongoing development of our NanoFlu™ and RSV F vaccines, a strong rationale exists for developing a combination respiratory vaccine that is designed to protect susceptible populations against both diseases. Although testing is at an early stage, we believe that a combination vaccine against both seasonal influenza and RSV may be ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Older adults (aged 60 years and older) are at increased risk for RSV disease due in part to immunosenescence, the age-related decline in the human immune system. RSV infection can also lead to exacerbation of underlying comorbidities such as chronic obstructive pulmonary disease, asthma, and congestive heart failure. In the United States alone, a reported RSV incidence rate of 5.5% in older ...
Manufactured by:BlueWillow Biologics based inAnn Arbor, MICHIGAN (USA)
BlueWillow’s intranasal vaccine technology has demonstrated safety and immunogenicity in Phase 1 clinical studies using a seasonal influenza vaccine. Several other ongoing BlueWillow programs — including intranasal vaccines for anthrax, pandemic influenza, RSV, HSV-2 and chlamydia — have recently advanced through successful ...
Manufactured by:KM Biologics Co. Ltd. based inKumamoto, JAPAN
An inactivated quadrivalent split (HA) seasonal influenza vaccine produced using embryonated chicken eggs. The vaccine contains 15 μg or more of HA proteins for each strain per adult dose. The strains used to make the vaccine are decided by the MHLW each ...
Manufactured by:Menssana Research Inc. based inEdgewater, NEW JERSEY (USA)
Seasonal influenza is a common respiratory illness that presents with annual cough and fever epidemics. In the USA, the total economic burden of annual influenza epidemics amounted to $87.1 billion in 2003, arising mainly from outpatient visits, hospitalization, time lost from work, and premature death. The economic and clinical burdens of ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
In March 2020, we announced positive top-line results from our Phase 3 clinical trial of our nanoparticle seasonal quadrivalent influenza vaccine candidate, including our proprietary Matrix-M™ adjuvant (NanoFlu™). The trial was a randomized, observer-blinded, active-controlled trial in approximately 2,652 healthy older adults (aged 65 years and older) ...
Manufactured by:CSL Seqirus UK Limited based inMaidenhead, UNITED KINGDOM
As a global leader in influenza protection, Seqirus has one of the broadest influenza vaccine portfolios in the world. In the Asia Pacific region we also provide access to a wide range of vaccines and specialty medicines that meet unique, local public health needs. Our broad range influenza vaccines meets the needs of different populations around the world. Our marketed product range varies from ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Carbocisteine is an orally active mucolytic agent. Carbocisteine attenuates the phosphorylation of NF-κB p65 and ERK1/2. Carbocisteine modulates Nrf2/HO-1 and NFκB interplay. Carbocisteine inhibits Apoptosis. Carbocisteine is used in chronic obstructive pulmonary disease (COPD) ...
Manufactured by:Altimmune Inc. based inGaithersburg, MARYLAND (USA)
Identical vector technology used for AdCOVID (COVID-19), NasoVAX (seasonal influenza) and NasoShield (anthrax) ...